<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02748226</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0463</org_study_id>
    <nct_id>NCT02748226</nct_id>
  </id_info>
  <brief_title>Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb Artery Diseases: (A Retrospective &amp; Prospective Observational Study)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Study design: multicenter retrospective and prospective observational study

        2. Study Cohort :

             1. Retrospective cohort: This cohort retrospectively enrolls patients with lower
                extremity artery disease who underwent endovascular treatment from January 2006 to
                the date of approval by IRB in the participating hospitals. Informed consent was
                waived by IRB.

             2. Prospective cohort: This cohort prospectively enrolls patients with lower extremity
                artery disease who undergo endovascular treatment from the date of approval by IRB
                to July, 2018 in the participating hospitals. Informed consent will be obtained
                prior to enrollment.

        3. Baseline clinical and lesion characteristics, procedural and post-procedural data,
           clinical outcomes, hemodynamic, and imaging follow-up data are investigated. Primary
           patency and target lesion revascularization rates of the total cohort and patient
           subgroups are evaluated. Risk factors of restenosis and target lesion revascularization
           are determined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study. The study includes patients who underwent endovascular
      treatments for lower extremity artery diseases and investigates immediate and late outcomes
      of the treatments. The investigator does not assign any specific interventions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Primary patency</measure>
    <time_frame>12 months</time_frame>
    <description>Primary patency is defined as freedom from more than 50% restenosis based on CT angiography, duplex ultrasound or catheter-based angiography or from clinically-driven target lesion revascularization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization (TLR)</measure>
    <time_frame>12 months</time_frame>
    <description>Any re-intervention within the target lesion due to symptom aggravation or drop of ankle brachial index (ABI) &gt;0.15 when compared to post procedure baseline.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">7000</enrollment>
  <condition>Peripheral Arterial Disease(PAD)</condition>
  <arm_group>
    <arm_group_label>Retrospective cohort</arm_group_label>
    <description>This cohort retrospectively enrolls patients with lower extremity artery disease who underwent endovascular treatment from January 2006 to the date of approval by IRB in the participating hospitals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospective cohort</arm_group_label>
    <description>This cohort prospectively enrolls patients with lower extremity artery disease who undergo endovascular treatment from the date of approval by IRB to July, 2018 in the participating hospitals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endovascular treatment</intervention_name>
    <description>endovascular treatment</description>
    <arm_group_label>Retrospective cohort</arm_group_label>
    <arm_group_label>Prospective cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with lower extremity artery disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Retrospective data

               1. Age 20 years of older

               2. Patients in the treatment or trying about symptomatic peripheral artery disease
                  from January 2006 until IRB approval date

          -  Prospective data

               1. Age 20 years of older

               2. Patients in the treatment or trying about symptomatic peripheral artery disease
                  from IRB approval date

               3. Symptomatic peripheral artery disease:

          -  Moderate or severe claudication (Rutherford category 1 to 3)

          -  Critical limb ischemia (Rutherford category 4 to 6)

        Exclusion Criteria:

          -  Pregnant women or women with potential childbearing

          -  Moderate Alzheimer's disease, mental illness or neurological disease of more than
             those who can not understand the purpose of this clinical trials and Methods

          -  Life expectancy &lt;1 year due to comorbidity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donghoon Choi</last_name>
      <phone>82-2-2228-8460</phone>
      <email>cdhljy@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2016</study_first_submitted>
  <study_first_submitted_qc>April 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2016</study_first_posted>
  <last_update_submitted>December 29, 2016</last_update_submitted>
  <last_update_submitted_qc>December 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

